Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Ali Behbahani

AddedMar 31, 2024

UpdatedJun 24, 2026

Ali Behbahani

Ali Behbahani

Partner, Co-Head of Healthcare, New Enterprise Associates

Ali Behbahani's Career

New Enterprise Associates

New Enterprise Associates

Menlo Park, CA, US

Partner, Co-Head of Healthcare

Cvrx

Minneapolis, MN, US

Board Member· Board

Cardionomic

New Brighton, MN, US

Board Member· Board

Solace Therapeutics

Solace Therapeutics

Framingham, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Ali Behbahani's Career

New Enterprise Associates

New Enterprise Associates

Investment FirmInvestment Firm1977Menlo Park, CA, US

Partner, Co-Head of Healthcare

Recent news

Tomorrow's Titans: Vertical AINEA · 2025

Consumer AI: Personal IntelligenceNEA · 2025

NeueHealth to go private in $1.3B acquisition by New Enterprise AssociatesFierce Healthcare · 2025

Leadership at New Enterprise Associates

Aaron JacobsonPartner

Rick YangPartner, Head of Technology

Tony FlorenceCo-CEO

Scott D. SandellExecutive Chairman and Chief Investment Officer

Similar to New Enterprise Associates

NeoSan Francisco, CA, USest. 2017NeoSan Francisco, CA, US · est. 2017

San Francisco venture capital firm and startup accelerator.

Investment Firm

New Technology VenturesNewton, MA, USest. 2015New Technology VenturesNewton, MA, US · est. 2015

New Technology Ventures Inc: A US-based venture capital firm investing in cybersecurity, software, and healthcare IT.

Investment Firm8

Neu Venture CapitalNew York City, NY, USest. 2008Neu Venture CapitalNew York City, NY, US · est. 2008

Neu Venture Capital: A US-based firm specializing in venture capital services.

Investment Firm1

New Era Capital PartnersTel Aviv, Tel Aviv District, ILest. 2018New Era Capital PartnersTel Aviv, Tel Aviv District, IL · est. 2018

New Era Capital Partners: A venture capital firm investing in global, tech-focused enterprises.

Investment Firm7

Cvrx

Public$390.6M1602001Minneapolis, MN, US

Board Member· Board

Leadership at Cvrx

Mudit K JainBoard Member

Jim ShapiroBoard Member

Joseph P. SlatteryBoard Member

Geoff PardoBoard Member

Josep Ll. SanfeliuBoard Member

Nadim YaredBoard Member

Similar to Cvrx

BarologicsCarver, MN, USMedical Devicesest. 2017BarologicsCarver, MN, US · est. 2017

Innovative medical tech company in Carver, MN treating hypertension with disruptive technology.

Series A · $11.5M6

CardieXItasca, IL, USHealthcare, Medical Devicesest. 2005CardieXItasca, IL, US · est. 2005

CardieX: A global health tech firm specializing in hypertension and cardiovascular disease solutions.

Public · $75k36

Vascular DynamicsMountain View, CA, USMedical Devices, Stentsest. 2008Vascular DynamicsMountain View, CA, US · est. 2008

Vascular Dynamics: US-based medical product provider specializing in stent implants for hypertension.

Series B · $105.1M24

MvrxBelmont, CA, USMedical Devicesest. 2009MvrxBelmont, CA, US · est. 2009

MVRx: A medical device company offering ARTO System, an innovative therapy for heart failure and mitral valve regurgitation.

Series A · $5.9M30

Cardionomic

Series A$49.8M282011New Brighton, MN, US

Board Member· Board

Leadership at Cardionomic

Michael DeManeBoard Member

Tara ButlerBoard Member

Tony BorowiczBoard Member

Steve GoedekeCEO

Similar to Cardionomic

Neocardial TechnologiesMinneapolis, MN, USMedical Devicesest. 2014Neocardial TechnologiesMinneapolis, MN, US · est. 2014

NeoCardial Technologies™, a Minneapolis-based medical device company, innovates heart failure treatment with its unique eHeart™ device.

Angel · $125k5

Cardiac DimensionsKirkland, WA, USMedical Devicesest. 2001Cardiac DimensionsKirkland, WA, US · est. 2001

US-based Cardiac Dimensions develops global medical devices for heart failure and mitral valve treatment.

Public · $209.7M62

Cardiac MotionSacramento, CA, USMedical DevicesCardiac MotionSacramento, CA, US

Cardiac Motion: Non-invasive home monitoring of pulmonary artery pressure for heart failure patients.

Pre-Seed · $1.2M7

Reprieve CardiovascularMilford, MA, USMedical Devicesest. 2018Reprieve CardiovascularMilford, MA, US · est. 2018

Reprieve Cardiovascular: A medical device company dedicated to enhancing outcomes for acute heart failure patients.

Series A · $49.1M17

Solace Therapeutics

Solace Therapeutics

Series B$36M82002Framingham, MA, US

Board Member· Board

Leadership at Solace Therapeutics

Kevin ConnorsBoard Member

John McDonoughBoard Member

Brian R. SmithBoard Member

Ryan DrantBoard Member

Stacy Enxing SengBoard Member

Similar to Solace Therapeutics

Solace PharmaceuticalsCambridge, MA, USPain Reliefest. 2006Solace PharmaceuticalsCambridge, MA, US · est. 2006

Solace Pharmaceuticals: Boston-based provider of therapeutic solutions for chronic pain.

Public · $15M5

Solenic MedicalCollege Station, TX, USMedical Devicesest. 2019Solenic MedicalCollege Station, TX, US · est. 2019

Solenic Medical: Innovating non-invasive solutions for infected metallic implant treatment.

Series A · $7.3M11

AxonicsIrvine, CA, USMedical Devicesest. 2012AxonicsIrvine, CA, US · est. 2012

California-based Axonics, Inc. designs and markets innovative, minimally invasive medical solutions globally.

Soleno TherapeuticsRedwood City, CA, USTherapeuticsest. 1999Soleno TherapeuticsRedwood City, CA, US · est. 1999

US-based Soleno Therapeutics develops and commercializes novel treatments for rare diseases.

Public · $160.5M25

Ali Behbahani's Similar Executives & Operators

Soemantri BrodjonegoroBoard Member · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

Chi-hyung SongBoard Member · Dunamu

WILL WEI CHENGBoard Member · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

JaeHong ChoiBoard Member · Kakao

Mason YeoBoard Member · Kakao

People Similar to Ali Behbahani

Amit MukherjeeBoard Member · Nextgen Partners

Suzanne KingBoard Member · Approva

Aaron JacobsonBoard Member · Second Front Systems

Andrew SchoenBoard Member · CCP Games

Phin BarnesCo-Founder · The

Richard WarburgBoard Member · Transparency Life Sciences